Dr. Keith Rennier has more than 13 years of biomedical research and development expertise in PCR, cell-based assays, signal transduction pathways and flow cytometry. His research has primarily focused on cellular mechanotransduction, tumor immunology and cancer biology.
He earned a PhD in biomedical engineering from Purdue University in 2015. As a postdoctoral research fellow at Washington University in St. Louis, Keith focused on assay development to delineate key oncogenic signaling pathways and immune cell recruitment in human tumors.